Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mona M. AlKhawajah"'
Autor:
Ibtisam A. Al Thubaiti, Mona M. AlKhawajah, Norah Al Fugham, Dema A. Alissa, Ahmed H. Al-Jedai, Yaser M. Al Malik, Mousa A. Almejally, Hajer Y. Al-Mudaiheem, Bedor A. Al-Omari, Hessa S. AlOtaibi, Rumaiza H. Al Yafeai, Mohammed A. Babakkor, Reem F. Bunyan, Edward J. Cupler, Mohammed Hakami, Hanaa M. Kedah, Seraj Makkawi, Leena H. Saeed, Jameelah A. Saeedi, Eslam Shosha, Mohammed A. Al Jumah
Publikováno v:
Clinical and Translational Neuroscience, Vol 7, Iss 1, p 6 (2023)
This article deals with recommendations on the management of symptoms of MS and on the provision of vaccinations in patients receiving disease-modifying therapies (DMTs). Symptoms of MS, such as fatigue, depression, urinary symptoms, spasticity, impa
Externí odkaz:
https://doaj.org/article/2183e4d78c6e4b98b414b3349982ffa1
Autor:
Yaser M. Al Malik, Ibtisam A. Al Thubaiti, Maha A. AlAmmari, Norah Al Fugham, Eman N. Ali, Dema A. Alissa, Salman A. Aljarallah, Ahmed H. Al-Jedai, Maeed A. AlKathiri, Mona M. AlKhawajah, Mousa A. Almejally, Hajer Y. Al-Mudaiheem, Hessa S. Al Otaibi, Ghadah H. AlTowaijri, Rumaiza H. Al Yafeai, Mohammed A. Babakkor, Saeed A. Bohlega, Reem F. Bunyan, Edward J. Cupler, Mohammed Hakami, Abid M. Kareem, Amr M. Khardaly, Seraj Makkawi, Leena H. Saeed, Jameelah A. Saeedi, Eslam Shosha, Mohammad A. Al Jumah
Publikováno v:
Clinical and Translational Neuroscience, Vol 6, Iss 4, p 27 (2022)
For the past 10 years, disease-modifying therapy (DMT) options for multiple sclerosis (MS) have grown remarkably where DMTs have been shown to reduce the risk of MS relapses. MS patients are advised to begin treatment with a DMT shortly after diagnos
Externí odkaz:
https://doaj.org/article/2fb7ce205ae64e98a94d6195cedec570
Autor:
Matthew Craner, Yaser Al Malik, Fawzi A. Babtain, Foziah Alshamrani, Mona M. Alkhawajah, Nora Alfugham, Rumaiza H. Al-Yafeai, Salman Aljarallah, Seraj Makkawi, Shireen Qureshi, Marina Ziehn, Hazem Wahba
Publikováno v:
Neurology and therapy. 11(4)
Treatment-pattern data suggest that some patients with multiple sclerosis (MS) in the Kingdom of Saudi Arabia (KSA) may not be receiving optimal treatment. A virtual meeting of ten expert Saudi neurologists, held on October 23, 2020, discussed unmet
Autor:
Pozzilli C; Multiple Sclerosis Center, Sant'Andrea Hospital, Rome, Italy.; Department of Human Neuroscience, University Sapienza, Rome, Italy., Pugliatti M; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.; Interdepartmental Center of Research for Multiple Sclerosis and Neuro-inflammatory and Degenerative Diseases, University of Ferrara, Ferrara, Italy., Vermersch P; Inserm U1172 LilNCog, CHU Lille, FHU Precise, University of Lille, Lille, France., Grigoriadis N; Laboratory of Experimental Neurology and Neuroimmunology, Second Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Alkhawajah M; Section of Neurology, Neurosciences Center, King Faisal Specialist Hospital and Research Center, College of Medicine, Al Faisal University, Riyadh, Kingdom of Saudi Arabia., Airas L; Division of Clinical Neurosciences, University of Turku, Turku, Finland.; Neurocenter of Turku University Hospital, Turku, Finland., Oreja-Guevara C; Department of Neurology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain.
Publikováno v:
European journal of neurology [Eur J Neurol] 2023 Jan; Vol. 30 (1), pp. 9-21. Date of Electronic Publication: 2022 Oct 25.
Autor:
Pugliatti M; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.; Interdepartmental Center of Research for Multiple Sclerosis and Neuro-inflammatory and Degenerative Diseases, University of Ferrara, Ferrara, Italy., Hartung HP; Department of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.; Brain and Mind Center, University of Sydney, Sydney, NSW, Australia.; Department of Neurology, Palacky University Olomouc, Olomouc, Czechia., Oreja-Guevara C; Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.; Faculty of Medicine, Complutense University of Madrid (UCM), Madrid, Spain., Pozzilli C; Multiple Sclerosis Center, S. Andrea Hospital, Department of Human Neuroscience, University Sapienza, Rome, Italy., Airas L; Division of Clinical Neurosciences, University of Turku, Turku, Finland.; Neurocenter of Turku University Hospital, Turku, Finland., Alkhawajah M; Section of Neurology, Neurosciences Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.; College of Medicine, Al Faisal University, Riyadh, Saudi Arabia., Grigoriadis N; Laboratory of Experimental Neurology and Neuroimmunology, Second Department of Neurology, American Hellenic Educational Progressive Association (AHEPA) University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Magyari M; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Van Wijmeersch B; Universitair Multiple Sclerosis (MS) Centrum, Hasselt-Pelt, Belgium.; Revalidatie & Multiple Sclerosis (MS), Noorderhart, Pelt, Belgium.; Rehabilitation Research Center (REVAL) & Biomedical Research Institute (BIOMED), Hasselt University, Hasselt, Belgium., Zakaria M; Department of Neurology, Ain Shams University, Cairo, Egypt., Linker R; Clinic and Polyclinic for Neurology, Universitätsklinikum Regensburg, Regensburg, Germany., Chan A; Department of Neurology, Inselspital Bern, Bern University Hospital, University of Bern, Bern, Switzerland., Vermersch P; University of Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France., Berger T; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Oct 17; Vol. 13, pp. 1045101. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).
Autor:
Van Wijmeersch B; Universitair Multiple Sclerosis (MS) Centrum, Hasselt-Pelt, Belgium.; Noorderhart, Revalidatie & Multiple Sclerosis (MS), Pelt, Belgium.; REVAL & BIOMED, Hasselt University, Hasselt, Belgium., Hartung HP; Department of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.; Brain and Mind Center, University of Sydney, Sydney, NSW, Australia.; Department of Neurology, Palacky University Olomouc, Olomouc, Czechia., Vermersch P; University Lille, Inserm U1172 LilNCog, Centre Hospitalier Universitaire (CHU) Lille, Fédératif Hospitalo-Universitaire (FHU) Precise, Lille, France., Pugliatti M; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.; Unit of Clinical Neurology, San Anna University Hospital, Ferrara, Italy., Pozzilli C; Department of Human Neuroscience, Sapienza University, Rome, Italy., Grigoriadis N; B' Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Alkhawajah M; Neuroscience Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Airas L; Turku University Hospital and University of Turku, Turku, Finland., Linker R; Department of Neurology, University Hospital Regensburg, Regensburg, Germany., Oreja-Guevara C; Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Cliínico San Carlos (IDISSC), Madrid, Spain.; Department of Medicine, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Sep 27; Vol. 13, pp. 991291. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Autor:
Alwatban S; King Faisal Specialist Hospital and Research Centre (KFSH&RC), Makkah Al Mukarramah Branch Rd, Al Mathar Ash Shamali, Riyadh 11564, Saudi Arabia., AlAamri E; Johns Hopkins Aramco Healthcare (JHAH), 6th Street, Gharb Al Dhahran, Dhahran 34465, Saudi Arabia., Alraffa A; King Faisal Specialist Hospital and Research Centre (KFSH&RC), Makkah Al Mukarramah Branch Rd, Al Mathar Ash Shamali, Riyadh 11564, Saudi Arabia., Alkhawajah M; King Faisal Specialist Hospital and Research Centre (KFSH&RC), Makkah Al Mukarramah Branch Rd, Al Mathar Ash Shamali, Riyadh 11564, Saudi Arabia.
Publikováno v:
Case reports in anesthesiology [Case Rep Anesthesiol] 2022 Feb 24; Vol. 2022, pp. 3082743. Date of Electronic Publication: 2022 Feb 24 (Print Publication: 2022).
Autor:
Al Jumah M; Neurology Department, King Fahad Medical City, Riyadh, Saudi Arabia. Electronic address: jumahm@gmail.com., Abulaban A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Department of Medicine, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia., Aggad H; Neurology Department, King Abdallah Medical Complex, Jeddah, Saudi Arabia., Al Bunyan R; Department of Neurology, Neurosciences Center, King Fahad Specialist Hospital Dammam, Saudi Arabia., AlKhawajah M; Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Riyadh Saudi Arabia., Al Malik Y; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; Division of Neurology, King Abdulaziz Medical City (National Guard Health Affairs), Riyadh, Saudi Arabia., Almejally M; Neurology Department, Heraa General Hospital, Makkah, Saudi Arabia., Alnajashi H; Neurology Division, Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia., Alshamrani F; Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Bohlega S; Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Jeddah Saudi Arabia., Cupler EJ; Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Jeddah Saudi Arabia., ElBoghdady A; Merck Serono Middle East FZ LTD, Riyadh, Saudi Arabia, an affiliate of Merck KGaA, Darmstadt, Germany., Makkawi S; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; Department of Medicine, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia., Qureshi S; Neurology Department, Johns Hopkins Aramco Healthcare (JHAH), Dhahran, Saudi Arabia., Shami S; Itkan Health Consulting, Riyadh, Saudi Arabia.
Publikováno v:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 Jun; Vol. 51, pp. 102925. Date of Electronic Publication: 2021 Mar 25.
Autor:
AlKhaja M; Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Electronic address: malkhaja70@kfshrc.edu.sa., Abanmy A; Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., AlKhdairi A; Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., AlRasheedi S; Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., AlZahrani H; Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., AlKhawajah M; Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Publikováno v:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2018 Oct; Vol. 25, pp. 334-336. Date of Electronic Publication: 2018 Aug 31.
Autor:
AlKhawajah M; Section of Neurology, Department of Neurosciences, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia., MacDonald DB, AlSemari A, AlThubaiti I, McLean D
Publikováno v:
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [Can J Neurol Sci] 2013 Jul; Vol. 40 (4), pp. 606-8.